BioCryst Pharmaceuticals, Inc.
- Sector
- Healthcare
- Industry
- Biotechnology
- ISIN
- US09058V1035
- CUSIP
- 09058V103
BCRXPrice Chart
Click Calculate to get results
BCRXPerformance
The chart shows the growth of $10,000 invested in BioCryst Pharmaceuticals, Inc. on Jan 5, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $21,618 for a total return of roughly 116.18%. All prices are adjusted for splits and dividends.
BCRXReturns in periods
| Period | Return |
|---|---|
| 1M | -4.05% |
| 6M | 21.99% |
| YTD | 97.32% |
| 1Y | 309.47% |
| 5Y | 26.68% |
| 10Y | 17.18% |
BCRXMonthly Returns Heatmap
Click Calculate to get results
BCRXDividends
BioCryst Pharmaceuticals, Inc. doesn't pay dividends
BCRXDrawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
BCRXWorst Drawdowns
The table below shows the maximum drawdowns of the BioCryst Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the BioCryst Pharmaceuticals, Inc. is 90.30%, recorded on Nov 14, 2019. It took 391 trading sessions for the portfolio to recover.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -90.3% | Jul 15, 2015 | 1094 | Nov 14, 2019 | 391 | Jun 7, 2021 | 1485 |
| -85.65% | Apr 30, 2010 | 714 | Mar 1, 2013 | 213 | Jan 3, 2014 | 927 |
| -42.56% | Mar 6, 2014 | 45 | May 8, 2014 | 37 | Jul 1, 2014 | 82 |
| -41.98% | Aug 11, 2014 | 157 | Mar 25, 2015 | 59 | Jun 18, 2015 | 216 |
| -25.55% | Jan 24, 2014 | 10 | Feb 6, 2014 | 12 | Feb 25, 2014 | 22 |
| -24.59% | Aug 6, 2021 | 41 | Oct 4, 2021 | — | — | — |
| -23.5% | Jan 12, 2010 | 20 | Feb 9, 2010 | 41 | Apr 9, 2010 | 61 |
| -17.74% | Jul 2, 2014 | 11 | Jul 17, 2014 | 12 | Aug 4, 2014 | 23 |
| -14.68% | Apr 13, 2010 | 11 | Apr 27, 2010 | 2 | Apr 29, 2010 | 13 |
| -10.67% | Jun 8, 2021 | 29 | Jul 19, 2021 | 4 | Jul 23, 2021 | 33 |
BCRXVolatility Chart
Current BioCryst Pharmaceuticals, Inc. volatility is 39.97%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.
Portfolios with BioCryst Pharmaceuticals, Inc.
Loading data...